Type
1.
Silva SR, de Souza SN, Santana MFS, Domingos AM, Martins N da S, de Paula HL, et al. Assessment of neuropathic pain, functional activity limitation and quality of life of people affected by leprosy in an endemic area in Northeast Brazil: a cross-sectional study. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2023;
Type
1.
Quintarelli L, Magnaterra E, Maglie R, Corrà A, di Calabria R, Aimo C, et al. Lepromatous leprosy presenting with erythema nodosum leprosum mimicking Bechet’s disease. Travel medicine and infectious disease [Internet]. 2022;52:102521. Available from: https://www.sciencedirect.com/science/article/pii/S1477893922002678/pdfft?md5=08c2e0fa5da159975e0b2eb3442ff63e&pid=1-s2.0-S1477893922002678-main.pdf
Type
1.
Pathak VK, Singh I, Singh SV, Sengupta U. Corroboration of cross-reactivity between and hosts’ salivary and cutaneous proteins: A hope for prognostic biomarkers for the pathogenesis of reactions in leprosy. Frontiers in microbiology [Internet]. 2022;13:1075053. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764389/pdf/fmicb-13-1075053.pdf
Type
1.
Morel R, Maddumabandara K, Amarasinghe N, Amarangani S, Amarasinghe A, Gunathilaka M, et al. Strongyloidiasis infection in a borderline lepromatous leprosy patient with adrenocorticoid insufficiency undergoing corticosteroid treatment: a case report. Journal of medical case reports [Internet]. 2022;16(1):458. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733215/pdf/13256_2022_Article_3673.pdf
Type
1.
Leung A, Arnold BJ, Hodgson TO, Cutfield NJ. Leprosy rash precipitated by immunotherapy for suspected inflammatory neuropathy. Practical neurology. 2022;
Type
1.
Masin PS, Visentin HA, Elpidio LNS, Sell AM, Visentainer L, Neto QADL, et al. Genetic polymorphisms of toll-like receptors in leprosy patients from southern Brazil. Frontiers in genetics [Internet]. 2022;13:952219. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596761/pdf/fgene-13-952219.pdf
Type
1.
Liu Y, Shi C, Ma S, Ma Y, Lu X, Zhu J, et al. The protective role of tissue-resident interleukin 17A-producing gamma delta T cells in Mycobacterium leprae infection. Frontiers in immunology [Internet]. 2022;13:961405. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644052/pdf/fimmu-13-961405.pdf
Type
1.
Pallares CD, Bourassa-Blanchette S, Fonseca K, Vaughan S. Leprosy: Challenges in diagnosis. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l’Association pour la microbiologie medicale et l’infectiologie Canada [Internet]. 2019;4(3):187-9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603024/pdf/jammi.2019.05.24.01.pdf
Type
1.
Sugawara-Mikami M, Tanigawa K, Kawashima A, Kiriya M, Nakamura Y, Fujiwara Y, et al. Pathogenicity and virulence of Mycobacterium leprae. Virulence [Internet]. 2022;13(1):1985-2011. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635560/pdf/KVIR_13_2141987.pdf
Type
1.
Yotsu RR, Miyamoto Y, Mori S, Ato M, Sugawara-Mikami M, Yamaguchi S, et al. Hansen’s disease (leprosy) in Japan, 1947-2020: An epidemiologic study during the declining phase to elimination. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Internet]. 2022; Available from: https://www.ijidonline.com/action/showPdf?pii=S1201-9712%2822%2900565-3
Pagination
- Previous page
- Page 25
- Next page